ADIPOQ and type 2 diabetes mellitus: Recent research revealed that the mRNA expression of adiponectin is reduced in obese diabetic murine model [9] and type 2 diabetic patients [10,11,12], and also plasma level of adiponcetin is significantly lower in obese diabetic mice and humans [13,14,15].